AbbVie (ABBV) Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has 4 years of Accumulated Expenses data on file, last reported at $411.0 million in Q4 2015.

• Accumulated Expenses for Q4 2015 came in at $411.0 million, down 49.94% year-over-year; the trailing twelve-month figure through Dec 2015 was $411.0 million (down 49.94% YoY), and the FY2015 annual result was $411.0 million, down 49.94% from the prior year.
• Accumulated Expenses fell to $411.0 million in Q4 2015 per ABBV's latest filing, from $821.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $821.0 million in Q4 2014 and troughed at $411.0 million in Q4 2015.
• A 4-year average of $594.0 million and a median of $572.0 million in 2012 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2014 and 2015: Accumulated Expenses soared 32.21% in 2014, then sank 49.94% in 2015.
• A 4-year view of Accumulated Expenses shows it stood at $523.0 million in 2012, then grew by 18.74% to $621.0 million in 2013, then soared by 32.21% to $821.0 million in 2014, then slumped by 49.94% to $411.0 million in 2015.
• Business Quant data shows ABBV's Accumulated Expenses at $411.0 million in Q4 2015, $821.0 million in Q4 2014, and $621.0 million in Q4 2013.